cell analysis global market-forecast to 2023

IQ4I Research & Consultancy Pvt. Ltd.

Cell Analysis Global Market

–Forecast to 2023

Cell Analysis Global Market estimated to be worth $47 billion by 2023 IQ4I Research & Consultancy published a new report on “Cell Analysis Global

Market – Forecast To 2023” This report analyzes and studies the overall market, major

drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and

Rest of the World

IQ4I’s Report Contains 158 market data tables and 43 figures spread through 526

pages and an exhaustive TOC on “Cell Analysis Global Market [TECHNIQUES

((Molecular-based approaches (PCR, Sequencing, Microfluidics & Microarrays, Cell

separation & isolation), Image-based approaches (Microscopy, Cytometry, High

content screening, FISH & Spectrophotometry)), PRODUCTS (Consumables,

Instruments & Softwares and Services), APPLICATIONS (By process, By-Field & By-

Therapeutic areas), END-USERS (Hospitals, Academic & Research Institutes, CROs,

Pharma & Biotech Companies, Cell Banks, Diagnostic Labs & Others), REGIONAL

(North America, Europe, Asia Pacific and Rest of the World)]

This report analyzes the Cell Analysis global market in terms of market revenue ($ million)

for all segments and it enables Cell Analysis stakeholders such as cell analysis product

manufacturers, pharma & biotech players, diagnostic laboratories, clinical laboratories and

hospitals, academic and research institutes to identify and analyze market expansion

opportunities, upcoming technologies and competition in cell analysis global market.

Cell Analysis is a wide term that can be correlated with a range of different technologies

depending on the experimental needs, from instruments to perform cellular imaging to

systems that help automate specific assays. This process enables to analyse cell signaling

mechanisms, elucidate molecular function, study cell behavior, and correlate multiple events

with cell morphology. Live cell imaging, single cell analysis, and high content screening

(HCS) are some of the few technological processes gaining more focus in the recent times.

Single-cell analysis is a rapidly evolving field which analyzes individual cells for assessment

of changing cell behavior and function over time during its natural states or when perturbed

by external factors. Single cell analysis is picking up a good position in cell analysis market

share because of its extensive application in cell research.

As estimated by IQ4I Research, Cell Analysis global market is expected to grow at a high

CAGR to reach $47,088 million by 2023. The booming healthcare technology market with

demand for innovative technology with early and accurate diagnosis of infectious diseases,

increasing government and corporate funding, high investment in cell- based research,

availability of reagents and advanced cell analysis instruments, higher demand from end

users such as diagnostic laboratories for cell analysis products are some of the factors



–Forecast to 2023

driving the cell analysis market growth. Emerging Asia Pacific cell analysis market, HCS

services by various service providers and automation in oncology research for early

diagnosis and cost-effective treatment are few oppurtunities for the cell analysis market.

However, stringent government regulations and patent related issues, lack of skilled

personnel to perform advanced cell analysis techniques, and the high cost of some of the

commercial instruments are expected to hamper the market growth.

The cell analysis market is mainly segmented by techniques, products, applications, end-

users and by geography. The cell analysis global market by the technique is segmented into

molecular approaches and image-based approaches. The molecular approach accounted for

the largest share in 2016 and the image-based approach is expected to grow at a strong

CAGR from 2016-2023. Among the various types of molecular approaches, PCR accounted

for largest revenue in 2016. But it is expected that the sequencing techniques has been

gaining huge momentum with strong from 2016-2023. Oxford Nanopore, one of the key

players in NGS technology, has recently launched a pocket NGS system MinION which has

successfully sequenced a number of human samples. The company has raised 127 million

of fundraising, for commercial activities and expansion in Asian countries. Among image

based approaches, Cytometry generated the largest revenue in 2016 due to various

technological advancements in the instruments and launch of various supporting software.

The FISH technique is expected to grow at a strong CAGR from 2016-2023 due to its ability

to study many cell features simultaneously in complex biology systems. Many companies

have been working intensively to strengthen their market presence in this segment by

launching new products. For instance, in September 2016, Agilent Technologies Inc.

launched a new CE-IVD labeled IQFISH lung cancer panel for automated analysis.

The cell analysis global market is segmented based on techniques, products, applications,

and end-users. The market by techniques is divided into Molecular based approaches and

image based approaches; based on products into consumables, instruments, software,

services and based on application into by process, by field and by therapeutic area

Based on process of application is segmented into cellular processes, signal transduction

pathways, circulating tumor cells, single cell analysis, epigenetic target analysis,

subpopulation characterization, drug and candidate screening. By field is further segmented

into forensic, therapeutics, cell imaging, biomarker research, genomic analysis, stem cell

analysis, and diagnostics. By therapeutics is further segmented into cancer research,

infectious disease diagnosis, genetic testing, immunology, and others.



–Forecast to 2023

The End-users consists hospitals, academic and research institutes, contract research

organizations (CROs), pharmaceuticals and biotechnology companies, cell banks, diagnostic

laboratories and others. The academics and research institutes contributed the largest

revenue as per estimates of IQ4I Research.

The cell analysis global market by geography is divided into North America, Europe, Asia-

Pacific and Rest of the World (RoW). North America commanded the largest market share in

2016 due to high investments in healthcare infrastructures, availability of government funds

improved market growth in this region. However, Asia-pacific region is expected to grow at

the highest CAGR due to increased healthcare awareness, improved economic growth, and

increasing disposable incomes

The major players in the cell analysis global market are Agilent Technologies, Inc. (U.S.),

Becton Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation

(U.S.), GE Healthcare (U.K.), Merck KGaA (Germany), Olympus Corporation (Japan),

PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Qiagen N.V. (Netherlands), and

ThermoFisher Scientific, Inc. (U.S.).

Reasons for buying this report:

Identification and analysis of the cell analysis market segments by techniques,

products, applications, end-users and geography

Analysis of the global market by identifying various sub-segments of the cell analysis

market

Revenue forecast of the cell analysis market and strategic analysis of each

submarket with respect to individual growth trends

Revenue forecast of the cell analysis market with respect to North America, Europe,

Asia-Pacific and the Rest of the World (RoW) regions

Identification of the major market trends and factors driving or inhibiting the growth of

the cell analysis global and its various sub-markets

Analysis of the opportunities for stakeholders by identifying the high-growth

segments of the market

Profiles of major players in the Cell analysis global market with details of their

product offerings, business strategies, SWOTs, market shares for overall market &

single cell analysis, live cell imaging market, funding scenario, upcoming technology,

and supply chain analysis



–Forecast to 2023

Established and Emerging players (141 companies) and their product offerings.

FIGURE 1

CELL ANALYSIS GLOBAL MARKET SEGMENTATION


By Techniques

Molecular

approachesConsumables

Softwares and

Services

Instruments Forensics

Therapeutics

Cell Imaging

Biomarker

research

Genomic

analysis

Stem cell

analysis

Diagnostics

Hospitals

By Products By Application By End Users

Image-based

approaches

PCR

Sequencing

Microfluidics &

Microarrays

Cell Separation

techniques

Microscopy

Cytometry

HCS

FISH

Spectrophotometry

By Process By FieldBy Therapeutic

area

Academics

CRO’s

Pharmaceuticals

& Biotech's

Cell banks

Laboratories

Others

Others

Cancer

research

Infectious

disease

Genetic

testing

Immunology

Cellular

processes

Signal

transduction

CTC

Single cell

analysis

Epigenetics

Drug discovery

Sub population

characterization